211 related articles for article (PubMed ID: 21292774)
1. G-CSF improves murine G6PC3-deficient neutrophil function by modulating apoptosis and energy homeostasis.
Jun HS; Lee YM; Song KD; Mansfield BC; Chou JY
Blood; 2011 Apr; 117(14):3881-92. PubMed ID: 21292774
[TBL] [Abstract][Full Text] [Related]
2. Lack of glucose recycling between endoplasmic reticulum and cytoplasm underlies cellular dysfunction in glucose-6-phosphatase-beta-deficient neutrophils in a congenital neutropenia syndrome.
Jun HS; Lee YM; Cheung YY; McDermott DH; Murphy PM; De Ravin SS; Mansfield BC; Chou JY
Blood; 2010 Oct; 116(15):2783-92. PubMed ID: 20498302
[TBL] [Abstract][Full Text] [Related]
3. Survival and differentiation defects contribute to neutropenia in glucose-6-phosphatase-β (G6PC3) deficiency in a model of mouse neutrophil granulocyte differentiation.
Gautam S; Kirschnek S; Gentle IE; Kopiniok C; Henneke P; Häcker H; Malleret L; Belaaouaj A; Häcker G
Cell Death Differ; 2013 Aug; 20(8):1068-79. PubMed ID: 23686134
[TBL] [Abstract][Full Text] [Related]
4. Glucose-6-phosphatase-β, implicated in a congenital neutropenia syndrome, is essential for macrophage energy homeostasis and functionality.
Jun HS; Cheung YY; Lee YM; Mansfield BC; Chou JY
Blood; 2012 Apr; 119(17):4047-55. PubMed ID: 22246029
[TBL] [Abstract][Full Text] [Related]
5. Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis.
McDermott DH; De Ravin SS; Jun HS; Liu Q; Priel DA; Noel P; Takemoto CM; Ojode T; Paul SM; Dunsmore KP; Hilligoss D; Marquesen M; Ulrick J; Kuhns DB; Chou JY; Malech HL; Murphy PM
Blood; 2010 Oct; 116(15):2793-802. PubMed ID: 20616219
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil dysfunction triggers inflammatory bowel disease in G6PC3 deficiency.
Goenka A; Doherty JA; Al-Farsi T; Jagger C; Banka S; Cheesman E; Fagbemi A; Hughes SM; Wynn RF; Hussell T; Arkwright PD
J Leukoc Biol; 2021 Jun; 109(6):1147-1154. PubMed ID: 32930428
[TBL] [Abstract][Full Text] [Related]
7. Mode of action of granulocyte-colony stimulating factor (G-CSF) as a novel therapy for stroke in a mouse model.
Modi J; Menzie-Suderam J; Xu H; Trujillo P; Medley K; Marshall ML; Tao R; Prentice H; Wu JY
J Biomed Sci; 2020 Jan; 27(1):19. PubMed ID: 31907023
[TBL] [Abstract][Full Text] [Related]
8. GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo.
Vroon A; Heijnen CJ; Raatgever R; Touw IP; Ploemacher RE; Premont RT; Kavelaars A
J Leukoc Biol; 2004 Apr; 75(4):698-704. PubMed ID: 14704365
[TBL] [Abstract][Full Text] [Related]
9. Altered Functions of Neutrophils in Two Chinese Patients With Severe Congenital Neutropenia Type 4 Caused by
Dai R; Lv G; Li W; Tang W; Chen J; Liu Q; Yang L; Zhang M; Tian Z; Zhou L; Yan X; Wang Y; Ding Y; An Y; Zhang Z; Tang X; Zhao X
Front Immunol; 2021; 12():699743. PubMed ID: 34305938
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-macrophage colony-stimulating factor delays neutrophil constitutive apoptosis through phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways.
Klein JB; Rane MJ; Scherzer JA; Coxon PY; Kettritz R; Mathiesen JM; Buridi A; McLeish KR
J Immunol; 2000 Apr; 164(8):4286-91. PubMed ID: 10754327
[TBL] [Abstract][Full Text] [Related]
11. Antiapoptotic effect of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and cyclic AMP on human neutrophils: protein synthesis-dependent and protein synthesis-independent mechanisms and the role of the Janus kinase-STAT pathway.
Sakamoto C; Suzuki K; Hato F; Akahori M; Hasegawa T; Hino M; Kitagawa S
Int J Hematol; 2003 Jan; 77(1):60-70. PubMed ID: 12568301
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
[TBL] [Abstract][Full Text] [Related]
13. A novel G6PC3 gene mutation in a patient with severe congenital neutropenia.
Aytekin C; Germeshausen M; Tuygun N; Dogu F; Ikinciogullari A
J Pediatr Hematol Oncol; 2013 Mar; 35(2):e81-3. PubMed ID: 23018568
[TBL] [Abstract][Full Text] [Related]
14. Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta.
Cheung YY; Kim SY; Yiu WH; Pan CJ; Jun HS; Ruef RA; Lee EJ; Westphal H; Mansfield BC; Chou JY
J Clin Invest; 2007 Mar; 117(3):784-93. PubMed ID: 17318259
[TBL] [Abstract][Full Text] [Related]
15. G-CSF activation of AKT is not sufficient to prolong neutrophil survival.
Souza LR; Silva E; Calloway E; Cabrera C; McLemore ML
J Leukoc Biol; 2013 Jun; 93(6):883-93. PubMed ID: 23559492
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor improves neurological function and angiogenesis in intracerebral hemorrhage rats.
Liang SD; Ma LQ; Gao ZY; Zhuang YY; Zhao YZ
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):2005-2014. PubMed ID: 29687856
[TBL] [Abstract][Full Text] [Related]
17. G6PC3 mutations are associated with a major defect of glycosylation: a novel mechanism for neutrophil dysfunction.
Hayee B; Antonopoulos A; Murphy EJ; Rahman FZ; Sewell G; Smith BN; McCartney S; Furman M; Hall G; Bloom SL; Haslam SM; Morris HR; Boztug K; Klein C; Winchester B; Pick E; Linch DC; Gale RE; Smith AM; Dell A; Segal AW
Glycobiology; 2011 Jul; 21(7):914-24. PubMed ID: 21385794
[TBL] [Abstract][Full Text] [Related]
18. A clinical and molecular review of ubiquitous glucose-6-phosphatase deficiency caused by G6PC3 mutations.
Banka S; Newman WG
Orphanet J Rare Dis; 2013 Jun; 8():84. PubMed ID: 23758768
[TBL] [Abstract][Full Text] [Related]
19. Induction of Bim limits cytokine-mediated prolonged survival of neutrophils.
Andina N; Conus S; Schneider EM; Fey MF; Simon HU
Cell Death Differ; 2009 Sep; 16(9):1248-55. PubMed ID: 19407828
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
